Retracted: Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer

Detalles Bibliográficos
Autor principal: Methods in Medicine, Computational and Mathematical
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322288/
https://www.ncbi.nlm.nih.gov/pubmed/37416228
http://dx.doi.org/10.1155/2023/9814782
_version_ 1785068720072163328
author Methods in Medicine, Computational and Mathematical
author_facet Methods in Medicine, Computational and Mathematical
author_sort Methods in Medicine, Computational and Mathematical
collection PubMed
description
format Online
Article
Text
id pubmed-10322288
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103222882023-07-06 Retracted: Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer Methods in Medicine, Computational and Mathematical Comput Math Methods Med Retraction Hindawi 2023-06-28 /pmc/articles/PMC10322288/ /pubmed/37416228 http://dx.doi.org/10.1155/2023/9814782 Text en Copyright © 2023 Computational and Mathematical Methods in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Methods in Medicine, Computational and Mathematical
Retracted: Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer
title Retracted: Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer
title_full Retracted: Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer
title_fullStr Retracted: Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer
title_full_unstemmed Retracted: Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer
title_short Retracted: Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer
title_sort retracted: clinical study of anti-pd-1 immunotherapy combined with gemcitabine chemotherapy in multiline treatment of advanced pancreatic cancer
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322288/
https://www.ncbi.nlm.nih.gov/pubmed/37416228
http://dx.doi.org/10.1155/2023/9814782
work_keys_str_mv AT methodsinmedicinecomputationalandmathematical retractedclinicalstudyofantipd1immunotherapycombinedwithgemcitabinechemotherapyinmultilinetreatmentofadvancedpancreaticcancer

Ejemplares similares